The path to longer and healthier lives for all Africans by 2030: the Lancet Commission on the future of health in sub-Saharan Africa

IA Agyepong, N Sewankambo, A Binagwaho… - The Lancet, 2017 - thelancet.com
Executive summary Sub-Saharan Africa's health challenges are numerous and wide-
ranging. Most sub-Saharan countries face a double burden of traditional, persisting health …

Use of malaria RDTs in various health contexts across sub-Saharan Africa: a systematic review

MR Boyce, WP O'Meara - BMC public health, 2017 - Springer
Abstract Background The World Health Organization recommends parasitological
confirmation of malaria prior to treatment. Malaria rapid diagnostic tests (RDTs) represent …

IMNets: Deep learning using an incremental modular network synthesis approach for medical imaging applications

R Ali, RC Hardie, BN Narayanan, TM Kebede - Applied Sciences, 2022 - mdpi.com
Deep learning approaches play a crucial role in computer-aided diagnosis systems to
support clinical decision-making. However, developing such automated solutions is …

Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in …

S Tougher, Y Ye, JH Amuasi, IA Kourgueni, R Thomson… - The Lancet, 2012 - thelancet.com
Background Malaria is one of the greatest causes of mortality worldwide. Use of the most
effective treatments for malaria remains inadequate for those in need, and there is concern …

Artemisinin resistance–modelling the potential human and economic costs

Y Lubell, A Dondorp, PJ Guérin, T Drake, S Meek… - Malaria journal, 2014 - Springer
Background Artemisinin combination therapy is recommended as first-line treatment for
falciparum malaria across the endemic world and is increasingly relied upon for treating …

“Recycling” classical drugs for malaria

C Teixeira, N Vale, B Perez, A Gomes… - Chemical …, 2014 - ACS Publications
Malaria has been a human health concern ever since the dawn of mankind, but despite the
huge struggles made to date to fight this infection, in 2012 over half a million people were …

[HTML][HTML] Estimated under-five deaths associated with poor-quality antimalarials in sub-Saharan Africa

JP Renschler, KM Walters, PN Newton… - The American journal …, 2015 - ncbi.nlm.nih.gov
Many antimalarials sold in sub-Saharan Africa are poor-quality (falsified, substandard, or
degraded), and the burden of disease caused by this problem is inadequately quantified. In …

Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications …

M Littrell, H Gatakaa, I Evance, S Poyer, J Njogu… - Malaria journal, 2011 - Springer
Background Access to artemisinin-based combination therapy (ACT) remains limited in high
malaria-burden countries, and there are concerns that the poorest people are particularly …

Subsidizing the distribution channel: Donor funding to improve the availability of malaria drugs

TA Taylor, W Xiao - Management Science, 2014 - pubsonline.informs.org
In countries that bear the heaviest burden of malaria, most patients seek medicine for the
disease in the private sector. Because the availability and affordability of recommended …

Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors

M Ocan, D Akena, S Nsobya, MR Kamya, R Senono… - Malaria journal, 2019 - Springer
Background Chloroquine, a previous highly efficacious, easy to use and affordable anti-
malarial agent was withdrawn from malaria endemic regions due to high levels of …